Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Jose Soler

Showing results (21-30 of 76) with videos related to

Pageof 8
Sort By:
Pharmaceutics|February 25, 2023
The Mitochondrion: A Promising Target for Kidney DiseaseCem Tanriover, Sidar Copur, Duygu Ucku, et al.
Journal of Clinical Medicine|October 27, 2022
Expert Clinical Management of Severe Immune-Related Adverse Events: Results from a Multicenter Survey on Hot Topics for ManagementMar Riveiro-Barciela, Maria Jose Soler, Ana Barreira-Diaz, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|June 10, 2018
Sex dimorphism in ANGII-mediated crosstalk between ACE2 and ACE in diabetic nephropathySergi Clotet-Freixas, Maria Jose Soler, Vanesa Palau, et al.
Clinical Kidney Journal|October 4, 2021
Tweet me: conferencing in the era of COVID-19 and 280 charactersKate I Stevens, Edoardo Melilli, Hugo Diniz, et al.
Journal of the American Society of Nephrology : JASN|May 6, 2020
Acute Kidney Injury in COVID-19: Emerging Evidence of a Distinct PathophysiologyDaniel Batlle, Maria Jose Soler, Matthew A Sparks, et al.
Clinical Kidney Journal|July 27, 2022
Semaglutide in type 2 diabetes with chronic kidney disease at high risk progression-real-world clinical practiceBeatriz Aviles Bueno, Maria Jose Soler, Luis Perez-Belmonte, et al.
Archives of Medical Research|December 23, 2023
Multidisciplinary Panel Consensus for the Management of Patients with Type 2 Diabetes: A Delphi StudyAna M Cebrián-Cuenca, Oscar Moreno-Pérez, Raquel Campuzano-Ruiz, et al.
Clinical Kidney Journal|July 8, 2026
Long-term eculizumab treatment failure in C3 glomerulonephritis: two case reportsDalia Zubidat, Maria Jose Soler, Anila Cara, et al.
Frontiers in Cardiovascular Medicine|May 26, 2023
Cardiorenal syndrome and diabetes: an evil pairingAna Belén Méndez Fernández, Ander Vergara Arana, Aleix Olivella San Emeterio, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 1, 2020
Sodium-glucose cotransporter 2 inhibition: towards an indication to treat diabetic kidney diseaseJose Luis Górriz, Juan F Navarro-González, Alberto Ortiz, et al.
Pageof 8

Showing results (21-30 of 76) with videos related to

Sort By:
Pageof 8
Pharmaceutics|February 25, 2023
The Mitochondrion: A Promising Target for Kidney DiseaseCem Tanriover, Sidar Copur, Duygu Ucku, et al.
Journal of Clinical Medicine|October 27, 2022
Expert Clinical Management of Severe Immune-Related Adverse Events: Results from a Multicenter Survey on Hot Topics for ManagementMar Riveiro-Barciela, Maria Jose Soler, Ana Barreira-Diaz, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|June 10, 2018
Sex dimorphism in ANGII-mediated crosstalk between ACE2 and ACE in diabetic nephropathySergi Clotet-Freixas, Maria Jose Soler, Vanesa Palau, et al.
Clinical Kidney Journal|October 4, 2021
Tweet me: conferencing in the era of COVID-19 and 280 charactersKate I Stevens, Edoardo Melilli, Hugo Diniz, et al.
Journal of the American Society of Nephrology : JASN|May 6, 2020
Acute Kidney Injury in COVID-19: Emerging Evidence of a Distinct PathophysiologyDaniel Batlle, Maria Jose Soler, Matthew A Sparks, et al.
Clinical Kidney Journal|July 27, 2022
Semaglutide in type 2 diabetes with chronic kidney disease at high risk progression-real-world clinical practiceBeatriz Aviles Bueno, Maria Jose Soler, Luis Perez-Belmonte, et al.
Archives of Medical Research|December 23, 2023
Multidisciplinary Panel Consensus for the Management of Patients with Type 2 Diabetes: A Delphi StudyAna M Cebrián-Cuenca, Oscar Moreno-Pérez, Raquel Campuzano-Ruiz, et al.
Clinical Kidney Journal|July 8, 2026
Long-term eculizumab treatment failure in C3 glomerulonephritis: two case reportsDalia Zubidat, Maria Jose Soler, Anila Cara, et al.
Frontiers in Cardiovascular Medicine|May 26, 2023
Cardiorenal syndrome and diabetes: an evil pairingAna Belén Méndez Fernández, Ander Vergara Arana, Aleix Olivella San Emeterio, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 1, 2020
Sodium-glucose cotransporter 2 inhibition: towards an indication to treat diabetic kidney diseaseJose Luis Górriz, Juan F Navarro-González, Alberto Ortiz, et al.
Pageof 8